Aptar reports second quarter 2026 results
Sales increased 6% to over $1 billion, net income $88 million, adjusted EPS $1.42.
See the latest news and media coverage for Aptar. We track all announcements, press releases, and industry mentions in real time, all in one place.
Drug and consumer product dosing, dispensing and protection technologies
aptar.comLast updated
In short: Aptar achieved record sales of over $1 billion in Q2 2026 and appointed Gael Touya as the new CEO to succeed Stephan Tanda in September.
Sales increased 6% to over $1 billion, net income $88 million, adjusted EPS $1.42.
It combines partner collaboration, system-level testing, and performance data to support earlier development decisions and address USP <382> expectations.
The valve’s stem design minimizes clogging and improves spray consistency, while local manufacturing in Illinois reduces lead times.
The report details environmental and social performance, including climate transition plans and independent assurance.
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities...
Q2 2026 earnings call recap: record ~$1B sales, EPS beat, pharma/GLP-1 demand, Beauty fixes, and Q3 EPS guide $1.45-$1.53—read now.
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Jul 30, 2026...
AptarGroup (NYSE:ATR) used its annual meeting to announce a planned chief executive transition, report that shareholders approved all items on the ballot and provide an...
Track Aptar and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Aptar and other trending companies.